Reducing the global burden of congenital rubella syndrome

The Lancet

Volumn 380, Issue 9848, 2012, Pages 1145-1146

  Reef, Susan E ^a   Chu, Susan Y ^a   Cochi, Stephen L ^a   Kezaala, Robert ^b   Van Den Ent, Maya ^b   Gay, Andrea ^c   De Quadros, Ciro ^d   Strebel, Peter M ^e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNICEF   (United States)

^c UN Foundation   (United States)

^d Albert B Sabin Vaccine Institute   (United States)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RUBELLA VACCINE;

CONGENITAL RUBELLA SYNDROME; FUNDING; HEALTH DISPARITY; HUMAN; INFECTION SENSITIVITY; LETTER; PRIORITY JOURNAL; VACCINATION;

EID: 84866720023     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61663-8     Document Type: Letter

References (4)

1. Cutts FT, Metcalf CJE, Lessler J, Grenfell BT. Rubella vaccination: must not be business as usual. Lancet 2012; 380: 217-18.
2. WHO. Rubella vaccines: WHO position paper. Wkly Epidemiol Rec 2011; 86: 301-16.
3. WHO. Global measles and rubella strategic plan: 2012-2020. http://www.who.int/immunization/newsroom/Measles-Rubella- StrategicPlan-2012- 2020.pdf (accessed Aug 3, 2012).
4. Metcalf CJE, Lessler J, Klepac P, Cutts F, Grenfell BT. Minimum levels of coverage needed for rubella vaccination: impact of local demography, seasonality and population heterogeneity. Epidemiol Infect 2012; 16:1-12.